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Abstract
Adenoid cystic carcinoma (ACC) of the breast is a rare neoplasm accounting for 0.1% of all breast
carcinomas, and presenting most commonly as a painful breast mass. In contrast to the aggressive
nature of ACC at other sites, ACC of the breast has a favorable prognosis, lymph node involvement
or distant metastases seldom occur. Treatment is basically of simple mastectomy. Chemotherapy,
radiation and hormonal treatment have been infrequently used and evaluated. We report a case of
ACC of the breast managed with mastectomy and review the literature.
Background
Adenoid cystic carcinoma (ACC) of the breast is a rare
breast cancer variant and optimal management is unclear.
Salivary gland tumors having the same histological pat-
tern as ACC of the breast were first termed "cylindroma"
by Billroth [2]. Although ACC of the breast can occur
between 30 and 90 years of age, it is more common in
women in the fifth and sixth decade of life [3]. Most
patients present with a dominant breast mass tender to
palpation [4,7]. Histologically, ACC has a unique distinc-
tive biphasic pattern that consists of true laminate and
pseudo- cystic spaces, true glands are lined by epithelial
cells and pseudocysts are lined by myoepithelial cells.
Cytologically, the tumor shows a typical pattern; globules
of mucous surrounded by epithelial cells with little cyto-
plasm and small hyperchromatic nuclei.
It reportedly has a better prognosis than most forms of
breast cancer and the incidence of axillary lymph node
metastases is lower [8]. Distant metastases are uncom-
mon, however when they occur they tend to do so without
prior lymph node involvement. It is generally estrogen
receptor (ER) and progesterone receptor (PR) negative.
Case presentation
A seventy-one-year-old single female presented with a
small tender lump in the inferior quadrant of her right
breast. Initial mammography and ultrasonography of the
breast were inconclusive. Her past medical history was sig-
nificant for vaginal hysterectomy at 45 years of age and
back surgery at 68 years of age for degenerative spine dis-
ease. Family history was negative for breast cancer but her
father had colon cancer. She was a non-smoker and did
not consume alcohol. Three weeks later examination
showed no change in size but increased tenderness. How-
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ever, no erythema, ecchymosis, skin ulceration or dim-
pling was seen. An excisional biopsy showed ACC. She
subsequently underwent a modified radical mastectomy
with axillary node dissection.
Pathology
The tumor measured 1.2 cm in maximum diameter. The
margins were free of carcinoma. Both the nuclear grade of
the lesion and the Bloom Richardson grade was 1. No
involvement of the nipple or the skin was present. Lymph
nodes were negative for tumor metastasis. The tumor was
staged, as T1N0M0, and was ER and PR negative. It was
DNA diploid with a low S-phase fraction. The Her-cep
test™ was negative.
Discussion
ACC of the breast is a rare neoplasm accounting for 0.1%
of all breast carcinomas [1]. It is of special interest because
of its favorable prognosis and distinctive histological
appearance [4]. Although ACC occurs predominantly in
females, male patients have been described in the litera-
ture [9,10]. ACC most frequently presents as a tender
breast mass, often in the subareolar area. Prognosis is
more favorable in ACC as compared to other types of
breast cancer as lymph node involvement and distant
metastasis are uncommon. In contrast to the aggressive
nature of the salivary gland tumors, ACC of the breast has
a favorable prognosis. The reason for this difference is
unexplained. As seen in our patient, most patients with
ACC have a mass when first diagnosed [12] and pain is
often the most common symptom [4,6]. Patients have
been reportedly monitored for more than a year with just
the symptom of breast pain before a mass or a radio-
graphic abnormality is detected [12]. In this case, the
patient complained of pain although the initial mam-
mography and the USG were inconclusive. Pain is also
seen in ACC of the salivary gland where the pain and the
tenderness are attributed to perineural invasion by the
tumor. However in our patient such invasion was absent.
This has been described in other series as well [12].
Although ACC of the breast is most commonly subareolar
in location, nipple discharge is an uncommon symptom
in ACC [13], and was not seen in our patient. Most ACC
are well circumscribed and firm. The diagnosis can be
made on fine needle aspiration cytology [14,15]. The
smears are highly cellular and contain extracellular
spheres of metachromatic material surrounded by uni-
form cells with scant cytoplasm. The tumor is mostly well
circumscribed in appearance and generally ranges from 1
to 5 cm in size [5]. Ro et al. suggested that ACC of the
breast can be graded on the proportion of solid growth of
the tumor and this was correlated with prognosis [16].
Grades proposed were 1 (no solid element); grade 2 (< 30
% solid element); grade 3 (>30% solid element). The pro-
posed treatment was local excision for grade 1 tumors,
simple mastectomy for grade 2 tumors and mastectomy
with axillary node dissection for grade 3 tumors. Although
calcification may develop in these tumors, only infre-
Table 1: Adenoid cystic carcinoma of the breast: At a glance.
Incidence:
• 0.1% of all breast cancers.
Age at presentation:
• 30 to 90 (mostly in 5th and 6th decade of life).
Most common presentation:
• Painful breast mass.
Mammography (role):
• Limited as compared to other breast cancers (may miss the tumor).
Lymph node involvement:
• Uncommon.
Metastases:
• Rare (can occur without LN involvement).
Most common site of metastases:
• Lung.
Management Options:
Surgery
• Simple Mastectomy (most widely performed).
• Lumpectomy followed by radiation (alternative option).
• Modified radical mastectomy (falling out of favor, considered too radical).
Radiation:
• Insufficiently evaluated (follows lumpectomy).
Chemotherapy:
• Not studied.
Hormonal manipulation:
• Of limited value as most cases are ER & PR negative.Publish with BioMed Central    and   every 
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quently are they detected by mammography. In our
patient the initial mammogram was inconclusive as
screening mammography often misses the tumor. In
another series only 4 of 22 patients detected radiologically
[12]. Axillary lymph node metastases are rare in patients
with ACC. Arpino et al. noted lymph node metastases in
only 4 of the 182 cases collected from the literature [3].
Distant metastases are uncommon with only 14 cases hav-
ing been reported, but when they occur they tend to do so
without prior lymph node involvement. Hence a routine
axillary LN dissection is not recommended [3].
ACC is generally ER negative; in various series the ER was
described as positive in 0.7% to 28 % of the cases [12,17].
PR was positive in 3 of the 13 evaluated patients [12]. The
best surgical treatment for ACC of the breast has not been
established. Local excision is followed by unacceptably
high rates of recurrence [8]. The studies showed that ACC
has low proliferation activity which may explain the low
recurrence rate. Based on these findings simple mastec-
tomy or lumpectomy followed by radiation treatment is
thought to have a chance to achieve adequate local con-
trol of nearly all tumors [3-12].
Despite its infrequent use, our patient had a modified rad-
ical mastectomy. Neither adjuvant chemotherapy nor hor-
monal manipulation has been studied in patients with
ACC of the breast. No conclusions have been drawn
regarding radiation and chemotherapy. Since it is a rare
neoplasm clinical trials comparing treatment options for
ACC are needed to define the optimal treatment.
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100× magnification of the breast mass showing islands of cells  with a characteristic cribriform pattern with a fibrous  desmoplastic background Figure 1a
100× magnification of the breast mass showing islands of cells 
with a characteristic cribriform pattern with a fibrous 
desmoplastic background. H & E stain.
400× magnification view showing the cribriform architecture  with some lumen containing bluish material Figure 1b
400× magnification view showing the cribriform architecture 
with some lumen containing bluish material. Also seen are 
the characteristic balls of eosinophilic material. H & E stain.Publish with BioMed Central    and   every 
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